The Middle East & Africa blood collection tubes for liquid biopsy market was valued at US$ 2,753.47 million in 2023 and is expected to reach US$ 9,859.41 million by 2031; it is estimated to register a CAGR of 17.3% from 2023 to 2031.
Liquid biopsy has revolutionized the way cancer disease states are detected and monitored. Circulating tumor cell (CTC) tubes, intracellular RNA tubes, circulating cell-free DNA (ccfDNA) tubes, cell-free RNA (cfRNA) tubes, genomic DNA (gDNA) tubes, and more advanced blood collecting tubes are available for liquid biopsy. The ccfDNAs, cfRNAs, and extracellular vehicles (EVs, also known as exosomes) are widely used due to which they are gaining considerable attention in cancer diagnosis. Disease-specific exosome or cfRNA analyses require draw-time concentrations of these analytes preserved in collected samples. Major market players focus on introducing new technologically advanced products in the market.
In November 2023, Illumina, Inc., launched TruSight Oncology 500 ctDNA v2, a research assay that enables noninvasive comprehensive genomic profiling (CGP) of circulating tumor DNA (ctDNA) from blood when tissue testing is not feasible; the assay is also performed to complement tissue-based testing. In February 2024, Delfi Diagnostics, in collaboration with Immunocore Holdings plc, launched a new cancer monitoring test to examine blood for broken pieces of tumor DNA to explore its use in the detection of multiple malignancies. The DELFI-TF assay delivers a genome-wide measure of the proportion of cfDNA that is derived from a tumor, and it is highly correlated with the mutant allele fraction that is used to evaluate treatment response and resistance to immunotherapies in patients suffering from advanced-stage cancer conditions.
Thus, technological advancements in liquid biopsies for the detection of cancer are expected to introduce new growth trends in the Middle East & Africa blood collection tubes for liquid biopsy market in the coming years.
South Africa is experiencing significant developments in healthcare facilities and infrastructure due to increased healthcare expenditure by the government. The country is also expected to receive investments from global pharmaceutical and medical device manufacturers, which is expected to create lucrative opportunities for the healthcare infrastructure.
Strategic insights for the Middle East & Africa Blood Collection Tubes for Liquid Biopsy provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Middle East & Africa Blood Collection Tubes for Liquid Biopsy refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Middle East & Africa Blood Collection Tubes for Liquid Biopsy Strategic Insights
Middle East & Africa Blood Collection Tubes for Liquid Biopsy Report Scope
Report Attribute
Details
Market size in 2023
US$ 2,753.47 Million
Market Size by 2031
US$ 9,859.41 Million
Global CAGR (2023 - 2031)
17.3%
Historical Data
2021-2022
Forecast period
2024-2031
Segments Covered
By Product
By Material
By Application
By End User
Regions and Countries Covered
Middle East and Africa
Market leaders and key company profiles
Middle East & Africa Blood Collection Tubes for Liquid Biopsy Regional Insights
The Middle East & Africa blood collection tubes for liquid biopsy market is categorized into product, material, application, end user, country.
By product, the Middle East & Africa blood collection tubes for liquid biopsy market is segmented into ccfDNA/cfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, intracellular RNA Tubes, and others. The ccfDNA/cfDNA Tubes segment held the largest share of the Middle East & Africa blood collection tubes for liquid biopsy market share in 2023.
In terms of material, the Middle East & Africa blood collection tubes for liquid biopsy market is segmented into plastic and glass. The plastic segment held a larger share of the Middle East & Africa blood collection tubes for liquid biopsy market share in 2023.
By application, the Middle East & Africa blood collection tubes for liquid biopsy market is bifurcated into in-vitro diagnostics (IVD) and research. The in-vitro diagnostics (IVD) segment held a larger share of the Middle East & Africa blood collection tubes for liquid biopsy market share in 2023.
In terms of end user, the Middle East & Africa blood collection tubes for liquid biopsy market is segmented into genetic diagnostic labs, research and development centers, conventional diagnostic centers, and others. The genetic diagnostic labs segment held the largest share of the Middle East & Africa blood collection tubes for liquid biopsy market share in 2023.
Based on country, the Middle East & Africa blood collection tubes for liquid biopsy market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa segment held the largest share of Middle East & Africa blood collection tubes for liquid biopsy market in 2023.
Biocept Inc; Exact Sciences Corp; F. Hoffmann-La Roche Ltd; Greiner Bio-One International GmbH; MagBio Genomics, Inc; Norgen Biotek Corp; QIAGEN NV; Streck Inc; and Zymo Research Corporation are some of the leading companies operating in the Middle East & Africa blood collection tubes for liquid biopsy market.
The Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market is valued at US$ 2,753.47 Million in 2023, it is projected to reach US$ 9,859.41 Million by 2031.
As per our report Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market, the market size is valued at US$ 2,753.47 Million in 2023, projecting it to reach US$ 9,859.41 Million by 2031. This translates to a CAGR of approximately 17.3% during the forecast period.
The Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market report:
The Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Blood Collection Tubes for Liquid Biopsy Market value chain can benefit from the information contained in a comprehensive market report.